COVID-19 vaccination and leprosy-A UK hospital-based retrospective cohort study.

Barbara De BarrosRachel PierceCathryn SprengerEugene Liat Hui OngStephen L Walker

Published in: PLoS neglected tropical diseases (2023)

The development of BT leprosy and a Type 1 reaction in another individual shortly after a dose of BNT162b2 vaccine may be associated with vaccine mediated T cell responses. The benefits of vaccination to reduce the risk of severe COVID-19 outweigh these unwanted events but data from leprosy endemic countries may provide further information about potential adverse effects of augmented T cell responses in individuals with leprosy or latent M. leprae infection.

Keyphrases

coronavirus disease
sars cov
early onset
healthcare
emergency department
social media
climate change
adverse drug